Trial Profile
A pharmacokinetic phase I study of SHP-680
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2017
Price :
$35
*
At a glance
- Drugs TAK 680 (Primary)
- Indications Cognition disorders
- Focus Pharmacokinetics
- 07 Aug 2017 New trial record